November 20, 2024 argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
November 11, 2024 argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
Follow us
Get the latest news and info via our social media channels.